Biocon starts clinical study to evaluate efficacy of Itolizumab
This is a phase-II randomised, double-blind, parallel-group, placebo and active-controlled (adalimumab), two-treatment period…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Ulcerative Colitis treatment
Roivant and Pfizer launch unit to develop inflammatory disease drug
The drug's efficacy as a treatment for ulcerative colitis is currently being assessed in a mid-stage study
Pfizer announces positive results for phase-III trial of Etrasimod in Ulcerative Colitis patients
Elevate 12 study met primary and key secondary endpoints of improving clinical remission at week 12